Measures to minimize cross-contamination risks in Advanced Therapy Medicinal Product manufacturing
Current European regulations define in vitro expanded cells for clinical purposes as substantially manipulated and include them in the class of Advanced Therapy Medicinal Products to be manufactured in compliance with current Good Manufacturing Practice. These quality requirements are generally thou...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
ScienceOpen
2014-11-01
|
Series: | ScienceOpen Research |
Online Access: | https://www.scienceopen.com/document?vid=0af59c6f-7bac-44a9-8164-ce0c06b5192b |